These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1946182)

  • 1. Drug interaction effects on antitumour drugs (X): exacerbation of cisplatin lethality by bacterial lipopolysaccharide in mice.
    Ishikawa M; Takayanagi Y; Sasaki K
    Pharmacol Toxicol; 1991 May; 68(5):366-70. PubMed ID: 1946182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against cisplatin nephrotoxicity by prochlorperazine.
    Kramer RA
    Cancer Chemother Pharmacol; 1989; 25(3):156-60. PubMed ID: 2598405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of cisplatin lethality by bacterial lipopolysaccharide pretreatment in mice.
    Ishikawa M; Ohzeki R; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1990 Dec; 70(3):375-8. PubMed ID: 2093216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lipopolysaccharide on the appearance of macrophage populations and fibrogenesis in cisplatin-induced rat renal injury.
    Yamate J; Machida Y; Ide M; Kuwamura M; Sawamoto O; LaMarre J
    Exp Toxicol Pathol; 2004 Oct; 56(1-2):13-24. PubMed ID: 15581271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna.
    DeWoskin RS; Riviere JE
    Toxicol Appl Pharmacol; 1992 Feb; 112(2):182-9. PubMed ID: 1311464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of disopyramide and verapamil on renal disposition and nephrotoxicity of cisplatin in rats.
    Hanada K; Odaka K; Kudo A; Ogata H
    Pharm Res; 1999 Oct; 16(10):1589-95. PubMed ID: 10554102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of paraquat lethality in mice by bacterial lipopolysaccharide pretreatment.
    Hollinger MA
    J Pharmacol Exp Ther; 1984 Aug; 230(2):292-4. PubMed ID: 6086882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interaction effects on antitumor drugs. XIII. Amelioration of cisplatin lethality and renal toxicity by chlorpromazine in mice.
    Ishikawa M; Takayanagi Y; Sasaki K
    Biol Pharm Bull; 1993 Nov; 16(11):1104-7. PubMed ID: 8312864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of cisplatin toxicity and lethality by juzen-taiho-to in mice.
    Sugiyama K; Ueda H; Ichio Y; Yokota M
    Biol Pharm Bull; 1995 Jan; 18(1):53-8. PubMed ID: 7735251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin pharmacokinetics and its nephrotoxicity in diabetic rabbits.
    Najjar TA; Saad SY
    Chemotherapy; 2001; 47(2):128-35. PubMed ID: 11173815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacological, toxicological and antitumoral evaluation of free and liposome-encapsulated cisplatin in rodents.
    Gondal JA; Preuss HG; Swartz R; Rahman A
    Eur J Cancer; 1993; 29A(11):1536-42. PubMed ID: 8217358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of cepharanthin on cisplatin-induced renal toxicity through metallothionein expression.
    Sogawa N; Hirai K; Sogawa C; Ohyama K; Miyazaki I; Tsukamoto G; Asanuma M; Sasaki A; Kitayama S
    Life Sci; 2013 Apr; 92(12):727-32. PubMed ID: 23399700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of mercury-induced nephrotoxicity by endotoxin in the mouse.
    Rumbeiha WK; Fitzgerald SD; Braselton WE; Roth RA; Pestka JJ; Kaneene JB
    Toxicology; 2000 Oct; 151(1-3):103-16. PubMed ID: 11074305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sodium thiosulfate on the pharmacokinetics of unchanged cisplatin and on the distribution of platinum species in rat kidney: protective mechanism against cisplatin nephrotoxicity.
    Nagai N; Hotta K; Yamamura H; Ogata H
    Cancer Chemother Pharmacol; 1995; 36(5):404-10. PubMed ID: 7634382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
    Aleisa AM; Al-Majed AA; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Al-Shabanah OA; Sayed-Ahmed MM
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1252-9. PubMed ID: 17973863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the nephrotoxicity in the mouse during repeated cisplatin (CDDP) treatments.
    Yajima Y; Kawaguchi M; Yoshikawa M; Okubo M; Tsukagoshi E; Sato K; Katakura A
    J Pharmacol Sci; 2017 Jun; 134(2):108-115. PubMed ID: 28648300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity in rats: importance of area under the concentration-time curve (AUC) as the major toxicodynamic determinant in vivo.
    Nagai N; Ogata H
    Cancer Chemother Pharmacol; 1997; 40(1):11-8. PubMed ID: 9137523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penetration of cisplatin into mouse brain by lipopolysaccharide.
    Minami T; Okazaki J; Kawabata A; Kuroda R; Okazaki Y
    Toxicology; 1998 Sep; 130(2-3):107-13. PubMed ID: 9865478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin-loaded polymer-metal complex micelle with time-modulated decaying property as a novel drug delivery system.
    Nishiyama N; Kato Y; Sugiyama Y; Kataoka K
    Pharm Res; 2001 Jul; 18(7):1035-41. PubMed ID: 11496942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of cisplatin-induced kidney injury using an integrated rodent platform.
    Chen Y; Brott D; Luo W; Gangl E; Kamendi H; Barthlow H; Lengel D; Fikes J; Kinter L; Valentin JP; Bialecki R
    Toxicol Appl Pharmacol; 2013 May; 268(3):352-61. PubMed ID: 23415679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.